Meeta Vyas Email

Chief Financial Officer . NanoViricides

Current Roles

Employees:
7
Revenue:
$1.1M
About
Official LinkedIn Page of NanoViricides, Inc NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against viruses. NanoViricides is a public company, currently trading on the NYSE under the ticker symbol NNVC
NanoViricides Address
1 Controls Drive
West Haven, CT
NanoViricides Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.